Project

RICE: An open label, randomized study to compare the efficacy of Certolizumab pegol (CZP) plus a dynamic or fixed dose treatment strategy in patients with Rheumatoid Arthritis, a phase II study

Completed · 2014 until 2018

Type
Clinical Studies
Range
Multicentric, KSSG as main centre
Units
Status
Completed
Start Date
2014
End Date
2018
Financing
Others
Keywords
fortgeschrittene RA, Gelenksinfiltration, Certolizumab
Brief description/objective

randomisierte Studie bei fortgeschrittener rheumatoider Arthritis mit Certolizumab, Standardtherapie DMARD/Prednison plus Certolizumab vs Therapieeskalation DMARD/Prednison mit Certolizumab und Gelenksinfiltration.